Approval · Notice of Compliance 20152 · 2017
TEVA-CEFADROXIL: Notice of Compliance 20152
Issued December 11, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 20152
- Date
- December 11, 2017
- Company
- Teva Canada LimitedToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to the product monograph with respect to dosing instructions for children and to be compliant with plain language label requirements
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TEVA-CEFADROXIL | Not yet assigned | — |
Medicinal ingredients
- CEFADROXIL MONOHYDRATE 500 MG per CAP